Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell membranes and sulfhydryl-containing enzymes represent a composite target for various broad-spectrum antimicrobial agents, particularly heavy metal compounds and certain antiseptics. The microbial cell membrane is a critical phospholipid bilayer that regulates the transport of nutrients and maintains the structural integrity of the cell (StatPearls, 2023). Sulfhydryl-containing enzymes are proteins that possess essential cysteine residues, which are vital for their catalytic function and overall microbial metabolism (NCBI, 2022). Antimicrobial agents like thimerosal or silver nitrate interact with these targets by disrupting membrane permeability and forming stable mercaptides with enzyme thiol groups, leading to rapid cell death (PubChem, 2024). This multi-target approach provides broad-spectrum activity against bacteria, fungi, and some viruses. However, because human cells also contain similar membrane structures and thiol-dependent enzymes, these agents often exhibit significant toxicity if used systemically. Therefore, they are primarily utilized in topical formulations, disinfectants, or as preservatives in vaccines and ophthalmic solutions (WHO, 2021). The lack of high specificity makes these targets effective against many resistant strains but significantly limits their therapeutic index in clinical practice.
Antimicrobial agents exert their effects by disrupting the structural integrity of microbial cell membranes, leading to the leakage of essential cytoplasmic contents, and by covalently binding to the sulfhydryl (-SH) groups of essential enzymes, which inactivates them through the formation of stable mercaptides (StatPearls, 2023; NCBI, 2022).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell membranes and sulfhydryl-containing enzymes.